Navigation Links
U.S. Bests Canada, Europe in Drug Approvals
Date:5/16/2012

WEDNESDAY, May 16 (HealthDay News) -- New drugs are approved faster in the United States than in Europe and Canada, new research shows.

The findings counter a common belief that the drug-approval process by the U.S. Food and Drug Administration is especially slow, according to Yale University School of Medicine researchers.

The study authors reviewed drug-approval decisions made between 2001 and 2010 by the FDA, Health Canada (the Canadian drug regulator), and the European Medicines Agency (EMA). The latter agencies were chosen for comparison with the FDA because they face similar pressures to approve new drugs quickly while ensuring patient safety, the researchers said.

"Among the subsample of drugs approved for all three regulators, the FDA's reviews were over three months faster than those of the EMA or Health Canada," study leader Nicholas Downing, a second-year medical student, said in a university news release.

"The total review time at the FDA was faster than EMA, despite the FDA's far higher proportion of applications requiring multiple regulatory reviews," he added.

The study also revealed that most new drug therapies were first approved for use in the United States.

"Examining novel drugs approved in multiple markets, we found that 64 percent of medicines approved in both the U.S. and in Europe were approved for U.S. patients first, and 86 percent of medicines approved in both the U.S. and Canada were also approved first in the U.S.," Downing said.

The study was published online May 16 in the New England Journal of Medicine.

More information

The FDA explains how it approves drugs.

-- Robert Preidt

SOURCE: Yale University, news release, May 16, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. ‘Leading' the Bestseller Race: Today We Publish —Tomorrow We Prevail!
2. Brown Rice Bests White for Diabetes Prevention
3. TAO l: The Way of All Life, by Zhi Gang Sha Reaches #6 on New York Times Bestseller List
4. Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
5. Grays Anatomy for Students, worlds bestselling anatomy textbooks, now available on iPad
6. Experimental Psoriasis Drug Bests Older Treatment
7. New procedure bests standard of care for fixing damaged cartilage
8. Report: For every 1 homeless person in Canada, another 23 live in inadequate housing
9. End-of-Life Care Differs Between U.S., Canada, Study Finds
10. New High Purity Immunoglobulin Enters Phase III in Europe and the US
11. Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Bests Canada, Europe in Drug Approvals
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: